Merck Spins Out Biosimilars And Legacy Brands

New Company To Include Women’s Health, Legacy Brands And Biosimilars

 
• By Dave Wallace

Merck has announced plans to spin off its Biosimilars, Women’s Health and Legacy Brands units into a separate company.

Merck_New_Jersey
Merck is spinning off its biosimilars, legacy and women’s health units • Source: Shutterstock

More from Strategy

More from Business